KeyBanc analyst Aleksey Yefremov raised the firm’s price target on Westlake to $107 from $103 and keeps an Underweight rating on the shares. The firm is cautiouson the chlor-alkali chain as demand has been weak with abundant supply, and says demand for PE has been "mediocre" and is slightly lower y/y, which has been an issue getting price traction, the analyst tells investors in a research note.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on WLK:
- Westlake price target raised to $122 from $118 at Barclays
- Westlake price target raised to $130 from $110 at Piper Sandler
- Westlake downgraded to Sector Perform from Outperform at RBC Capital
- Westlake price target raised to $103 from $95 at KeyBanc
- Westlake price target raised to $120 from $105 at Deutsche Bank